CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
dose levels of CLR 125 in patients with advanced triple negative breast cancer. The main questions the study aims to answer are:* W ...
Phase 1
Princeton, New Jersey, United States and 2 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Philadelphia, Pennsylvania, United States and 19 other locations
This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...
Phase 2
West Reading, Pennsylvania, United States and 4 other locations
The goal of this clinical trial is to study the safety, feasibility, histologic and immunological effects of Mitazalimab, a CD40 agonistic antibody,...
Early Phase 1
Philadelphia, Pennsylvania, United States
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...
Phase 2
Philadelphia, Pennsylvania, United States and 6 other locations
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...
Phase 2
Philadelphia, Pennsylvania, United States and 17 other locations
contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis -...
Philadelphia, Pennsylvania, United States and 10 other locations
A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer....
Phase 1
Princeton, New Jersey, United States and 6 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Flemington, New Jersey, United States and 78 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Philadelphia, Pennsylvania, United States and 32 other locations
Clinical trials
Research sites
Resources
Legal